EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of gastrointestinal tract lesions and serum malondialdehyde levels after repeated oral administration of phenylbutazone in horses

Parichart Tesena, Ruethaiwan Vinijkumthorn, Titirat Preuksathaporn, Poonnada Piyakul, Thanapon Chotikaprakal, Rannaree Sirireugwipas, Kanokpich Wong-Aree, Nawarus Prapaiwan

Veterinary Research Communications · 2024

DOI: 10.1007/s11259-024-10415-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Research Communications, 2024. Verfasst von Parichart Tesena und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences and Public Health, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, 73170, Thailand. Hauptthemen laut MEDLINE: Phenylbutazone, Malondialdehyde, Horse Diseases, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phenylbutazone (PBZ) is a widely used nonsteroidal anti-inflammatory drug for horses. However, because of its gastrointestinal side effects, its administration requires careful attention in veterinary practice. Malondialdehyde (MDA) is a serum biomarker associated with increased damage to the equine gastrointestinal system. This study investigated the hematological effects and alterations in the gastrointestinal tract and assessed serum MDA concentrations following repeated oral PBZ administration at clinical doses. Fourteen horses were randomly divided into control and treatment groups. All horses in the treatment group were administered 4.4 milligrams per kilogram of body weight of PBZ syrup orally twice a day for 7 days, whereas the control group received syrup as a placebo. The development of gastrointestinal side effects was investigated using gastroscopy, abdominal ultrasound, and fecal pH; serum MDA concentrations were assessed using a commercially available enzyme-linked immunosorbent assay kit. Data were compared between PBZ-treated and control horses before and after the treatment period. The treatment group exhibited decreased albumin and total protein concentrations. Moreover, this group exhibited a higher thickness of the right dorsal colon wall ( p = 0.03) and had higher scores for squamous gastric ulcers ( p = 0.01). Fecal pH was lower in the treatment group than in the control group after PBZ administration ( p < 0.01). Although MDA concentrations were higher in the treatment group after PBZ administration, they did not differ significantly from those of the control group. This study highlighted the changes in hematological and gastrointestinal lesions resulting from PBZ administration in horses at clinical doses, even without clinical signs. However, MDA may not be an optimal biomarker for the early detection of gastrointestinal damage due to PBZ treatment in horses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylbutazoneMalondialdehydeHorse DiseasesAnti-Inflammatory Agents, Non-SteroidalAnimalsHorsesAdministration, OralMaleFemaleGastrointestinal DiseasesGastrointestinal Tract

Stichwörter der Autor:innen

Abdominal ultrasoundEquineEquine gastric ulcer syndromeGastroscopyNSAIDsOxidative stress

Substanzen

PhenylbutazoneMalondialdehydeAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Clinical Sciences and Public Health, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, 73170, Thailand.
  • Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, 73170, Thailand.
  • Veterinary and Remount Department, Royal Thai Army Animal Hospital, Nakhon Pathom, 73000, Thailand.
  • Department of Clinical Sciences and Public Health, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, 73170, Thailand. nawarus.pra@mahidol.edu.

Förderung

  • Mahidol University

Zitieren

APA

Tesena, P., Vinijkumthorn, R., Preuksathaporn, T., Piyakul, P., Chotikaprakal, T., Sirireugwipas, R., Wong-Aree, K., & Prapaiwan, N. (2024). Evaluation of gastrointestinal tract lesions and serum malondialdehyde levels after repeated oral administration of phenylbutazone in horses. Veterinary Research Communications. https://doi.org/10.1007/s11259-024-10415-y

Vancouver

Tesena P, Vinijkumthorn R, Preuksathaporn T, Piyakul P, Chotikaprakal T, Sirireugwipas R, et al. Evaluation of gastrointestinal tract lesions and serum malondialdehyde levels after repeated oral administration of phenylbutazone in horses. Veterinary Research Communications. 2024. doi:10.1007/s11259-024-10415-y

BibTeX
@article{Tesena2024,
  author = {Tesena, Parichart and Vinijkumthorn, Ruethaiwan and Preuksathaporn, Titirat and Piyakul, Poonnada and Chotikaprakal, Thanapon and Sirireugwipas, Rannaree and Wong-Aree, Kanokpich and Prapaiwan, Nawarus},
  title = {Evaluation of gastrointestinal tract lesions and serum malondialdehyde levels after repeated oral administration of phenylbutazone in horses},
  journal = {Veterinary Research Communications},
  year = {2024},
  doi = {10.1007/s11259-024-10415-y}
}
Kostenlos starten →